- Home
- TCBS vs RFL Comparison
TCBS vs RFL Comparison
Compare TCBS & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBS
- RFL
- Stock Information
- Founded
- TCBS 1934
- RFL 2017
- Country
- TCBS United States
- RFL United States
- Employees
- TCBS N/A
- RFL N/A
- Industry
- TCBS Banks
- RFL Real Estate
- Sector
- TCBS Finance
- RFL Finance
- Exchange
- TCBS Nasdaq
- RFL Nasdaq
- Market Cap
- TCBS 47.0M
- RFL 48.4M
- IPO Year
- TCBS N/A
- RFL N/A
- Fundamental
- Price
- TCBS $15.00
- RFL $2.40
- Analyst Decision
- TCBS
- RFL
- Analyst Count
- TCBS 0
- RFL 0
- Target Price
- TCBS N/A
- RFL N/A
- AVG Volume (30 Days)
- TCBS 1.5K
- RFL 65.0K
- Earning Date
- TCBS 11-20-2024
- RFL 12-12-2024
- Dividend Yield
- TCBS 1.07%
- RFL N/A
- EPS Growth
- TCBS N/A
- RFL N/A
- EPS
- TCBS N/A
- RFL N/A
- Revenue
- TCBS $9,785,000.00
- RFL $540,000.00
- Revenue This Year
- TCBS N/A
- RFL N/A
- Revenue Next Year
- TCBS N/A
- RFL N/A
- P/E Ratio
- TCBS N/A
- RFL N/A
- Revenue Growth
- TCBS N/A
- RFL 92.86
- 52 Week Low
- TCBS $11.78
- RFL $1.29
- 52 Week High
- TCBS $15.24
- RFL $2.44
- Technical
- Relative Strength Index (RSI)
- TCBS 69.21
- RFL 87.25
- Support Level
- TCBS $14.75
- RFL $2.00
- Resistance Level
- TCBS $14.90
- RFL $1.94
- Average True Range (ATR)
- TCBS 0.05
- RFL 0.10
- MACD
- TCBS -0.01
- RFL 0.03
- Stochastic Oscillator
- TCBS 100.00
- RFL 94.85
About TCBS Texas Community Bancshares Inc.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd.